About This Fund
Cantos Ventures is a San Francisco-based venture capital firm founded in 2016 by Ian Rountree, specializing in what it calls "near frontier" technology — deeply technical, often capital-intensive companies that are transforming the physical world. The firm backs science-forward founders at the earliest stages (pre-seed and seed), concentrating on sectors including climate technology, biotechnology, aerospace and defense, and next-generation computing. Cantos targets companies where the technology itself is the primary moat, and where the founding team typically includes domain scientists or engineers solving hard infrastructure, energy, or biotech challenges.
Cantos Ventures III is the firm's third flagship fund, closing at $50 million in September 2022. The fund continued the firm's thesis of backing "near frontier" startups — companies working on problems such as climate change mitigation, infectious disease, conflict reduction, and existential risk. Fund III maintained the firm's early-stage discipline, writing first checks at pre-seed and seed into technically ambitious teams before the broader venture market developed conviction. The vehicle reflects a deliberate focus on scientific-founder-led companies operating at the intersection of physical-world impact and cutting-edge computation or materials science.
By 2022, Cantos had backed over 60 companies and counted multiple unicorns in its portfolio, including Astranis (satellite broadband) and Solugen (industrial synthetic biology). Fund III continued investing in that lineage. The firm's earlier funds demonstrated that deep-tech bets at pre-seed, when conviction is based on science rather than product-market fit, can produce outsized outcomes as hard-tech infrastructure spending accelerates globally. Cantos went on to close a $70 million Fund IV in 2024, focused on defense, aerospace, and deep tech — validating the franchise's continued LP appetite and Rountree's long-term thesis on science-led entrepreneurship.